![]() Galectin Therapeutics Galectin Therapeutics uses galectin science and drug development to create new therapies for fibrotic diseases and cancer. | ![]() Merrimack Pharmaceuticals Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer. | ||
Founding Date | Founding Date 2001 | Founding Date 2000 | Founding Date 2006 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Norcross, US HQ | Locations Cambridge, US HQ | Locations Salt Lake City, US HQ |
Employees | Employees 717% increase | Employees 2763% decrease | Employees 13 |
Valuation ($) | Valuation ($) 155.1 m | Valuation ($) 223.7 m | Valuation ($) N/A |
Financial | |||
Net income | Net income ($30.8m) (FY, 2025) | Net income ($1.2m) (FY, 2023) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 79.4m | Total funding raised $ 1.7m |

Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
View companyNavigen is a pharmaceutical discovery and development company.
View company